However, the higher stage, more aggressive serous adenocarcinomas and carcinosarcomas did display significantly higher PLAC1 expression than the lower stage, less aggressive endometrioid tumors (Figure 3). This evidence concerns the gene PLAC1 and endometrioid tumor.